Given its higher detectability, stronger association with vesicular trafficking, and potentially closer link to AD-related cellular processes, salivary flotillin-1 may provide greater stability as a peripheral biomarker compared with salivary Aβ. Here, FLOT1 is linked to Alzheimer disease.